Peter B. Bach is listed as an executive officer on 2 SEC Form D filings by 1 issuer between Jul 2022 and Dec 2025: Delfi Diagnostics, Inc. (Palo Alto, CA — biotechnology — 2022–2025; $225M reported sold to 50 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Elizabeth Homans (2 shared filings), Greg Yap (2 shared filings), Jacob Van Naarden (2 shared filings), Justin Kao (2 shared filings), Michael Dybbs (2 shared filings) and 8 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Peter. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 5 bankruptcy cases matching the name listed in Key records below.
What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Peter B. Bach and found 7 differences: Form D filed 17 days after the first sale; Form D filed 45 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.